Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Kalbe Farma Tbk (KLBF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Kalbe Farma Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 118.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | KLBF | |
|---|---|---|
Market Cap | 316.25B | 37.45T |
Volume | 41.7K | 41.79M |
Lot | 417 | 417.89K |
Turnover | 9.66M | 33.46B |
Average Price | 231.65 | 800.79 |
Value | 9.66M | 33.46B |
Indicative Equilibrium Price | 230 | 800 |
Indicative Equilibrium Volume | 2.4K | 18.3K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →
